Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

Ziad Farah, Sabreen Ali, Fiona Price-Kuehne, Charles G Mackworth-Young Department of Rheumatology, Charing Cross Hospital, London, UKObjectives: To evaluate the long-term efficacy and safety of tocilizumab (TCZ) in clinical patients with rheumatoid arthritis (RA) refractory to synthetic disease-modi...

Full description

Bibliographic Details
Main Authors: Farah Z, Ali S, Price-Kuehne F, Mackworth-Young CG
Format: Article
Language:English
Published: Dove Medical Press 2016-03-01
Series:Biologics: Targets & Therapy
Subjects:
tocilizumab
rheumatoid arthritis
refractory rheumatoid
long term
efficacy
safety
tolerability
Online Access:https://www.dovepress.com/tocilizumab-in-refractory-rheumatoid-arthritis-long-term-efficacy-safe-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/tocilizumab-in-refractory-rheumatoid-arthritis-long-term-efficacy-safe-peer-reviewed-article-BTT

Similar Items